Multiprofen-CC to Reduce Pain in Hand Arthritis
Multiprofen-CC to Reduce Pain in Hand Arthritis (MRP-HAND): A Crossover Randomized Controlled Trial
St. Joseph's Healthcare Hamilton
42 participants
Mar 9, 2026
INTERVENTIONAL
Conditions
Summary
This clinical trial aims to find out if using 1 gram of Multiprofen-CC cream on the hands three times a day for 4 weeks can help reduce pain in adults with hand osteoarthritis, compared to a placebo (a cream with no active medicine). The research team will also look at how Multiprofen-CC affects hand function, opioid use, and how patients feel about their overall improvement. In addition, the research team will keep track of any side effects. Participants will: * Use both Multiprofen-CC and a placebo (a cream with no active medicine) during the study, in a random order. * Be asked to apply 1 gram of cream to their hands three times a day for 2 weeks, following the manufacturer's instructions. * Attend a visit before starting the study, after 2 weeks, and after 6 weeks. * Report any symptoms they experience during the study.
Eligibility
Inclusion Criteria4
- Adults (18+)
- Have been diagnosed with hand osteoarthritis according to American College of Rheumatology criteria
- Experience pain and/or loss of function in one or both hands that interferes with daily life
- Provide informed consent
Exclusion Criteria9
- Unable to consent
- Unable or unwilling to follow study protocol
- Known allergy or contraindication to any of the study drugs or their ingredients
- Have open wounds/cuts and/or skin conditions on the hand area
- Pregnant or breastfeeding
- History of impaired kidney or liver function
- Rheumatoid or other inflammatory arthropathy
- Hand surgery within the past 6 months or planned within the study period.
- Use daily opioids (other than short acting codeine) for a chronic pain condition other than hand arthritis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard care pain medications and topical Multiprofen-CC™ (1g TID) for 2 weeks
Standard care pain medications and visually identical topical placebo (1g TID) for 2 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06966206